Comparison on the occurrence of bleeding related events in influenza outpatients by treatment status using health insurance claims database
Latest Information Update: 18 May 2022
At a glance
- Drugs Baloxavir-marboxil (Primary) ; Laninamivir; Oseltamivir; Peramivir; Zanamivir
- Indications Influenza virus infections
- Focus Adverse reactions
- Sponsors Shionogi
- 20 Dec 2021 New trial record
- 08 Dec 2021 Results published in the Pharmacoepidemiology and Drug Safety